Vancouver, BC, January 29, 2024--Variational AI, developer of the Enki generative artificial intelligence (AI) platform for drug discovery, announced a project with Merck Research Labs supported by the CQDM Quantum Leap program.
Vancouver, BC, January 10, 2023--ariational AI, developer of the Enki generative artificial intelligence (AI) drug discovery platform to redefine the economics of drug development, announced that the company has filed two provisional patents with the United States Patent and Trademark Office (USPTO) related to new chemical entities (NCE) successfully created using generative AI.
Vancouver, BC, November 30, 2022--Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, announced that it has added industry and scientific leader Jennifer Hamilton, Ph.D. as a company advisor.
Vancouver, BC, November 3, 2022--Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, announced that it has added industry and scientific leader Jennifer Hamilton, Ph.D. as a company advisor.